Clinical Trials Directory

Trials / Unknown

UnknownNCT02714478

"Equistasi" and Gait in Hemiparesis

Efficacy of "Equistasi" on the Gait of Patients Affected by Hemiparesis Due to Cerebrovascular Accident

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the effect of "Equistasi" device on quantitative and qualitative gait characteristics in patients affected by hemiparesis.

Conditions

Interventions

TypeNameDescription
DEVICEequistasi3 devices will be placed in each patient: 1 at the spinosus process of L5; 1 at the insertion of transverse abdominis; 1 at the insertion of the gluteus medius to the femur. The devices will be kept for 55 minutes, during standard Physiotherapy
DEVICEplacebo3 devices will be placed in each patient: 1 at the spinosus process of L5; 1 at the insertion of transverse abdominis; 1 at the insertion of the gluteus medius to the femur. The devices will be kept for 55 minutes, during standard Physiotherapy

Timeline

Start date
2015-04-01
Primary completion
2016-12-01
First posted
2016-03-21
Last updated
2016-09-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02714478. Inclusion in this directory is not an endorsement.